252 related articles for article (PubMed ID: 30924914)
1. Non-Melanoma Skin Cancer Tumor's Characteristics and Histologic Subtype as a Predictor for Subclinical Spread and Number of Mohs Stages required to Achieve Tumor-Free Margins.
Santos-Arroyo A; Carrasquillo OY; Cardona R; Sánchez JL; Valentín-Nogueras S
P R Health Sci J; 2019 Mar; 38(1):40-45. PubMed ID: 30924914
[TBL] [Abstract][Full Text] [Related]
2. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
Cerci FB; Kubo EM; Werner B; Tolkachjov SN
J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
[TBL] [Abstract][Full Text] [Related]
3. Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane.
Orengo IF; Salasche SJ; Fewkes J; Khan J; Thornby J; Rubin F
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):395-7. PubMed ID: 9308552
[TBL] [Abstract][Full Text] [Related]
4. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
Lim GF; Perez OA; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2022 Jun; 86(6):1309-1317. PubMed ID: 35231546
[TBL] [Abstract][Full Text] [Related]
5. Adamantinoid basal cell carcinoma: a predictor of more-aggressive clinical behavior.
Berk DR; Ball Arefiev KL; Gladstone HB
Dermatol Surg; 2012 Aug; 38(8):1346-50. PubMed ID: 22551358
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological factors influencing the number of stages of Mohs surgery for basal cell carcinoma.
Calvão J; Pinho A; Brinca A; Vieira R
An Bras Dermatol; 2022; 97(3):291-297. PubMed ID: 35379511
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis.
Sohn GK; Keniston K; Kannan S; Hinds B; Jiang SIB
J Drugs Dermatol; 2021 Mar; 20(3):283-288. PubMed ID: 33683071
[TBL] [Abstract][Full Text] [Related]
8. Micronodular basal cell carcinoma. A deceptive histologic subtype with frequent clinically undetected tumor extension.
Hendrix JD; Parlette HL
Arch Dermatol; 1996 Mar; 132(3):295-8. PubMed ID: 8607634
[TBL] [Abstract][Full Text] [Related]
9. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery.
Ratner D; Bagiella E
Dermatol Surg; 2003 Sep; 29(9):899-903. PubMed ID: 12930329
[TBL] [Abstract][Full Text] [Related]
11. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
Schell AE; Russell MA; Park SS
JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
[TBL] [Abstract][Full Text] [Related]
12. Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.
Fantini BC; Bueno Filho R; Chahud F; Souza CDS
J Dermatolog Treat; 2019 Feb; 30(1):74-80. PubMed ID: 29727201
[TBL] [Abstract][Full Text] [Related]
13. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
14. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery.
Batra RS; Kelley LC
Arch Dermatol; 2002 Aug; 138(8):1043-51. PubMed ID: 12164742
[TBL] [Abstract][Full Text] [Related]
15. Subclinical infiltration of Basal cell carcinoma in asian patients: assessment after mohs micrographic surgery.
Ro KW; Seo SH; Son SW; Kim IH
Ann Dermatol; 2011 Aug; 23(3):276-81. PubMed ID: 21909195
[TBL] [Abstract][Full Text] [Related]
16. Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread.
Hoorens I; Batteauw A; Van Maele G; Lapiere K; Boone B; Ongenae K
Br J Dermatol; 2016 Apr; 174(4):847-52. PubMed ID: 26595159
[TBL] [Abstract][Full Text] [Related]
17. How Wide Should the Excision Margins for Facial Small Aggressive Basal Cell Carcinoma Be? Experience With 306 Cases.
Ariza SA; Calderón DC; Aristizábal JC; Parra-Medina R
Dermatol Surg; 2020 Jun; 46(6):753-756. PubMed ID: 31567587
[TBL] [Abstract][Full Text] [Related]
18. Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence.
Català A; Garces JR; Alegre M; Gich IJ; Puig L
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1363-9. PubMed ID: 25383396
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
[TBL] [Abstract][Full Text] [Related]
20. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
van Kester MS; Goeman JJ; Genders RE
J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
